Skip to main content

Table 3 ANC attendance and IPTp-SP uptake among study participants

From: Intermittent preventive treatment of malaria in pregnancy: a cross-sectional survey to assess uptake of the new sulfadoxine–pyrimethamine five dose policy in Ghana

Characteristics Frequency (n = 255) Percentage (%)
Gestational age at first ANC
 First trimester 105 41.18
 Second trimester 126 49.41
 Third trimester 24 9.41
Number of ANC visits
 <4 29 11.37
 ≥4 226 88.63
Number of doses received
 None 3 1.18
 One dose 10 3.92
 Two doses 19 7.45
 Three doses 81 31.76
 Four doses 105 41.18
 Five doses 37 14.51
Gestational age at first dose of SP
 16 53 21.03
 17–24 165 65.48
 25–36 34 13.49
Number of SP tablets swallowed per dose during pregnancy
 2 3 1.2
 3 249 98.8
Place where SP was dispensed
 ANC 250 99.21
 Pharmacy 2 0.79
Stopped folic acid whiles taking SP drug
 Did not stop 249 98.8
 Stopped 3 1.2
Took SP drug under DOT
 Not directly observed 2 0.8
 Directly observed 250 99.2
  1. n number of respondents, ANC antenatal centre, SP sulphadoxine pyrimethamine, DOT direct observed therapy